Uric Acid and Diabetes: Is there a Link?

Author(s): Niki Katsiki, Nikolaos Papanas, Vivian A. Fonseca, Efstratios Maltezos, Dimitri P. Mikhailidis

Journal Name: Current Pharmaceutical Design

Volume 19 , Issue 27 , 2013

Become EABM
Become Reviewer
Call for Editor


Elevated serum uric acid (SUA) levels (i.e. hyperuricaemia) have been associated with metabolic syndrome (MetS) and cardiovascular disease (CVD) morbidity and mortality. Elevated SUA levels predict the onset of type 2 diabetes (T2DM). SUA levels are increased during the early stages of impaired glucose metabolism. Furthermore, in diabetic patients, hyperuricaemia has been linked to both micro- and macrovascular complications. The present review considers: (1) SUA levels in patients with MetS, type 1 diabetes and T2DM; (2) the mechanisms that influence SUA levels in these patients; (3) the potential links between SUA and diabetic complications. The effect on SUA levels of drugs commonly prescribed for T2DM and the risk of uric acid nephrolithiasis in patients with MetS or DM are also briefly discussed.

Keywords: Uric acid, type 1 diabetes, type 2 diabetes, diabetic complications, drugs.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2013
Published on: 25 June, 2013
Page: [4930 - 4937]
Pages: 8
DOI: 10.2174/1381612811319270016
Price: $65

Article Metrics

PDF: 99